Frequent Mutation of the PIK3CA Gene in Ovarian and Breast Cancers

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-04-2142
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

PIK3CA Mutation Predicts Resistance to Breast Cancer Therapy

Cancer Discovery
Oncology
2013English

Progesterone Action in Breast, Uterine, and Ovarian Cancers

Journal of Molecular Endocrinology
EndocrinologyMolecular Biology
2015English

Germline Mutations in the BRCA1 Gene Predisposing to Breast and Ovarian Cancers in Upper Silesia Population.

Acta Biochimica Polonica
BiochemistryGeneticsMolecular Biology
2002English

PIK3CA Gene Mutations in Breast Carcinoma in Malaysian Patients

Cancer Genetics and Cytogenetics
2008English

Beyond Breast and Ovarian Cancers: PARP Inhibitors for BRCA Mutation-Associated and BRCA-Like Solid Tumors

Frontiers in Oncology
Cancer ResearchOncology
2014English

Frequent Mutation of the P53 Gene in Human Esophageal Cancer.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1990English

Gene Amplification and Overexpression of PRDM14 in Breast Cancers

Cancer Research
Cancer ResearchOncology
2007English

Ets-1 Global Gene Expression Profile Reveals Associations With Metabolism and Oxidative Stress in Ovarian and Breast Cancers

Cancer & Metabolism
2013English

PIK3CA and PTEN Gene and Exon Mutation-Specific Clinicopathologic and Molecular Associations in Colorectal Cancer

Clinical Cancer Research
Cancer ResearchOncology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy